Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06225804
Title A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Abbisko Therapeutics Co, Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Precision NextGen Oncology RECRUITING Beverly Hills California 90212 United States Details
Anhui Chest Hospital NOT_YET_RECRUITING Hefei Anhui China Details
Fujian Cancer Hospital NOT_YET_RECRUITING Fuzhou Fujian China Details
The first Affiliated Hospital of Xi'an Jiaotong University NOT_YET_RECRUITING Xi'an Harbin China Details
Harbin Medical University Cancer Hospital NOT_YET_RECRUITING Harbin Heilongjiang China Details
Henan Cancer Hospital NOT_YET_RECRUITING Zhengzhou Henan China Details
Union Hospital Tongji Medical College Huzhong University of Science and Techology NOT_YET_RECRUITING Wuhan Hubei China Details
Hunan Cancer Hospital NOT_YET_RECRUITING Changsha Hunan China Details
The first Affiliated Hospital of Nanchang University NOT_YET_RECRUITING Nanchang Jiangxi China Details
Jilin Cancer Hospital NOT_YET_RECRUITING Changchun Jilin China Details
Central Hospital Affiliated to Shangdong of First Medical University NOT_YET_RECRUITING Jinan Shandong China Details
Shanghai Chest Hospital RECRUITING Shanghai Shanghai China Details
Sichuan Cancer Hospital NOT_YET_RECRUITING Chengdu Sichuan China Details
Zhejiang Caner Hospital NOT_YET_RECRUITING Hangzhou Zhejiang China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field